Natural Investments LLC bought a new position in shares of STERIS plc (NYSE:STE – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 1,628 shares of the medical equipment provider’s stock, valued at approximately $334,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of STE. Ashton Thomas Securities LLC acquired a new stake in STERIS during the third quarter worth about $25,000. Human Investing LLC acquired a new stake in STERIS during the fourth quarter worth about $31,000. Anfield Capital Management LLC grew its holdings in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division grew its holdings in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares during the period. Finally, Manchester Capital Management LLC grew its holdings in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 137 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the company. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Stephens reiterated an “overweight” rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $258.75.
STERIS Stock Performance
NYSE STE opened at $228.13 on Wednesday. The company has a market cap of $22.41 billion, a PE ratio of 48.44 and a beta of 0.92. The stock’s 50 day simple moving average is $217.94 and its 200-day simple moving average is $222.62. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.
STERIS (NYSE:STE – Get Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.
STERIS Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. STERIS’s payout ratio is 48.41%.
STERIS Company Profile
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles
- Five stocks we like better than STERIS
- How to Profit From Value Investing
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is Insider Trading? What You Can Learn from Insider Trading
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Calculate Inflation Rate
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.